NEW YORK (
CHANGE IN RATINGS, EPS
target raised at Citigroup to $35. Long term benefit from subscription likely to accrue to growth and margins. Buy rating.
estimates, target raised at Credit Suisse.Shares of AOL now seen reaching $17. Estimates also increased, as the company is realizing higher sales and keeping a tight lid on costs. Neutral rating.
rated new Overweight at Evercore. $600 price target. Company continues to grow, despite weak consumer sentiment.
Becton, Dickinson and Company
estimates cut at Citigroup through 2013 on weak guidance. Maintain $79 price target and Neutral rating.
rated new Outperform at Credit Suisse. $7.50 price target. Company is in the early stages of a multi-year turnaround.
downgraded at Morgan Stanley from Overweight to Equal-weight. Valuation call.
downgraded at Goldman from Neutral to Sell. Company faces multiple growth headwinds. $17 price target.
rated new Equal-weight at Evercore. $17.50 price target. Company still operates primarily in a commodity business.
estimates, target cut at Credit Suisse.Shares of DNDN now seen reaching $11. Estimates also reduced, given continued execution issues. Neutral rating.
estimates raised at UBS through 2012. Plans to bring in a JV partner across its New Ventures plays. Maintain $85 price target and Buy rating.
rated new Equal-weight at Evercore. $33 price target. Company is leveraged to multiple secular growth markets.
numbers boosted at Credit Suisse.Shares of FST now seen reaching $21. Estimates also upped, given solid production growth across the board. Outperform rating.
upgraded at Morgan Stanley from Equal-weight to Overweight. $28 price target. Services headwinds should soon begin to abate.
Fortinet rated new Neutral at UBS. $24 price target. Well positioned to ride strong secular multi year demand tailwinds, however share look fairly valued.
numbers lowered at Credit Suisse. Shares of FWLT now seen reaching $26. Estimates also cut, given the company's new guidance. Outperform rating.
Foster Wheeler numbers lowered at UBS. Shares of FWLT now seen reaching $28. Estimates also lowered as 2011 E&C revs are expected to be down y/y. Buy rating.
numbers reduced at Jefferies.Shares of GPRO now seen reaching $73. Estimates also cut, given lower utilization rates. Buy rating.
estimates lowered at UBS through 2011. Loss ratios at high end or worse than guidance. Maintain $38 price target and Buy rating.
numbers lowered at Citigroup. Shares of HCA now seen reaching $28. Estimates also lowered on elimination of TX UPL. Buy rating.
downgraded at Goldman from Buy to Neutral. $29 price target. Regulatory and competitive issues could are deteriorating in California.
rated new Underweight at Evercore. $29 price target. Company is losing share to competitors.
rated new Overweight at Evercore. $210 price target. Company is carrying a lot of operating momentum into 2012.
estimates, target raised at UBS.Shares of ICE now seen reaching $145. Estimates also increased on higher run rate volumes and a lower tax rate.
estimates increased at Citigroup through 2012. Pricing and productivity offsetting inflation. Maintain $42 price target and Buy rating.
Kraft Foods estimates increased at UBS through 2012. Strong top line growth and a higher tax rate in 4Q. Maintain $40 price target and Buy rating.
is upgraded to buy at TheStreet Ratings.
estimates, target raised at Citigroup.Shares of MA now seen reaching $360. Estimates also increased as spending remains robust. Neutral rating.
Mastercard estimates, target raised Jefferies.Shares of MA now seen reaching $401. Estimates also increased, given solid growth across the board. Buy rating.
rated new Outperform at Credit Suisse. $45 price target.
MEMC Electronic Materials
is downgraded to sell at TheStreet Ratings.
numbers raised at UBS.Shares of MUR now seen reaching $59, according to UBS. Estimates also increased on higher crude prices. Neutral rating.
estimates increased at UBS through 2013. Increased Film/Sat TV OI, partially offset by lower cable net. Maintain $19 price target and Neutral rating.
numbers cut at Credit Suisse. Shares of ONNN now seen reaching $8.50. Estimates also reduced, to match the company's new guidance. Neutral rating.
estimates cut at UBSPRU estimates lowered through 2011. Operating EPS misses consensus. Maintain $77 price target and Buy rating.
estimates, target raised at Citigroup.Shares of QCOM now seen reaching $62. Estimates also raised as company delivered above consensus expectations both near and long term. Buy rating.
Qualcomm estimates, target boosted at Credit Suisse.Shares of QCOM now seen reaching $70. Estimates also upped, as the company has several potential growth drivers. Outperform rating.
Research in Motion
target cut at Jefferies.Shares of RIMM now seen reaching $18. Smartphone market has reached an inflection point, regarding saturation. Underperform rating.
estimates increased at Morgan Stanley through 2012. Company is realizing higher margins. Overweight rating and $2 price target.
St. Jude Medical
rated new Neutral at Credit Suisse. Valuation call, based on a $43 price target. Company has decent growth visibility.
upgraded at Morgan Stanley from Equal-weight to Overweight. $47 price target. Estimates also boosted, given better expected domestic growth.
Teva Pharmaceuticals numbers cut at UBS.Shares of TEVA now seen reaching $60. Estimates also lowered on lowered 4Q guidance. Buy rating.
rated new Buy at UBS. $32 price target. New products gaining traction among customers.
downgraded at Argus from Buy to Hold. Weaker outlook is due to Saudi Arabia.
Tidewater estimates, target cut at Credit SuisseShares of TDW now seen reaching $56, according to Credit Suisse. Estimates also reduced, to match the company's new guidance. Outperform rating.
estimates increased at UBS through 2012. Film drives 3Q upside. Maintain $33 price target and Neutral rating.
numbers lowered at Jefferies. TRW estimates were cut through 2012. Legal expenses remains high. Buy rating and new $55 price target.
estimates cut at UBS through 2011. 4Q guided lower on deferrals. Maintain $147 price target and Buy rating.
downgraded at Stifel from Buy to Hold. Company slashed its sales guidance.
estimates upped at Morgan Stanley through 2012. Company continues to deliver solid growth. Equal-weight rating.
>To submit a news tip, email:
and become a fan on
This article was written by a staff member of TheStreet.